| Antimicrobial resistance is a global health emergency E Toner, A Adalja, GK Gronvall, A Cicero, TV Inglesby Health security 13 (3), 153-155, 2015 | 154 | 2015 |
| COVID-19 antibody tests: a valuable public health tool with limited relevance to individuals R West, A Kobokovich, N Connell, GK Gronvall Trends in microbiology 29 (3), 214-223, 2021 | 118 | 2021 |
| Global catastrophic biological risks: toward a working definition M Schoch-Spana, A Cicero, A Adalja, G Gronvall, T Kirk Sell, D Meyer, ... Health security 15 (4), 323-328, 2017 | 98 | 2017 |
| Clustering class I MHC modulates sensitivity of T cell recognition DR Fooksman, GK Grönvall, Q Tang, M Edidin The Journal of Immunology 176 (11), 6673-6680, 2006 | 90 | 2006 |
| The reemergent 1977 H1N1 strain and the gain-of-function debate M Rozo, GK Gronvall MBio 6 (4), 10.1128/mbio. 01013-15, 2015 | 88 | 2015 |
| The FDA animal efficacy rule and biodefense Alliance for Biosecurity Gronvall Gigi Kwik ggronvall@ upmc-biosecurity. org ... Nature biotechnology 25 (10), 1084-1087, 2007 | 56 | 2007 |
| The origins of Covid-19—why it matters (and why it doesn’t) LO Gostin, GK Gronvall New England Journal of Medicine 388 (25), 2305-2308, 2023 | 55 | 2023 |
| Information hazards in biotechnology G Lewis, P Millett, A Sandberg, A Snyder‐Beattie, G Gronvall Risk Analysis 39 (5), 975-981, 2019 | 50 | 2019 |
| Biosecurity implications for the synthesis of horsepox, an orthopoxvirus D DiEuliis, K Berger, G Gronvall Health security 15 (6), 629-637, 2017 | 48 | 2017 |
| Developing a national strategy for serology (antibody testing) in the United States G Gronvall, N Connell, A Kobokovich, R West, KL Warmbrod, MP Shearer, ... Johns Hopkins University, 2020 | 47 | 2020 |
| One health security: an important component of the global health security agenda G Gronvall, C Boddie, R Knutsson, M Colby Biosecurity and bioterrorism: biodefense strategy, practice, and science 12 …, 2014 | 44 | 2014 |
| Navigating the Storm: Report and Recommendations from the Atlantic Storm Exercise BT Smith, TV Inglesby, E Brimmer, L Borio, C Franco, GK Gronvall, ... Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 3 …, 2005 | 40 | 2005 |
| Assessing the bioweapons threat C Boddie, M Watson, G Ackerman, GK Gronvall Science 349 (6250), 792-793, 2015 | 36 | 2015 |
| The scientific response to COVID-19 and lessons for security GK Gronvall Survival 62 (3), 77-92, 2020 | 35 | 2020 |
| CRISPR cautions: Biosecurity implications of gene editing RM West, GK Gronvall Perspectives in biology and medicine 63 (1), 73-92, 2020 | 33 | 2020 |
| US competitiveness in synthetic biology GK Gronvall Health security 13 (6), 378-389, 2015 | 32 | 2015 |
| US medical countermeasure development since 2001: a long way yet to go PK Russell, GK Gronvall Biosecurity and bioterrorism: biodefense strategy, practice, and science 10 …, 2012 | 31 | 2012 |
| High-containment biodefense research laboratories: meeting report and center recommendations GK Gronvall, J Fitzgerald, A Chamberlain, TV Inglesby, T O'Toole Biosecurity and Bioterrorism 5 (1), 75-85, 2007 | 30 | 2007 |
| National priorities to combat misinformation and disinformation for COVID-19 and future public health threats: a call for a national strategy TK Sell, D Hosangadi, E Smith, M Trotochaud, P Vasudevan, G Gronvall, ... Johns Hopkins Center for Health Security, Baltimore, MD, 2021 | 29 | 2021 |
| Options for synthetic DNA order screening, revisited D DiEuliis, SR Carter, GK Gronvall MSphere 2 (4), 10.1128/msphere. 00319-17, 2017 | 26 | 2017 |
Matthew P ShearerJohns Hopkins Center for Health SecurityEmail yang diverifikasi di jhu.edu